Mark Schoenberg
2017
In 2017, Mark Schoenberg earned a total compensation of $1.1M as Chief Medical Officer at UroGen Pharma Ltd., a 69% decrease compared to previous year.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Non-Equity Incentive Plan | $6,030 |
| Option Awards | $468,708 |
| Salary | $13,636 |
| Stock Awards | $490,750 |
| Total | $1,054,124 |
Schoenberg received $490.8K in stock awards, accounting for 47% of the total pay in 2017.
Schoenberg also received $75K in bonus, $6K in non-equity incentive plan, $468.7K in option awards and $13.6K in salary.
Rankings
In 2017, Mark Schoenberg's compensation ranked 8,742nd out of 14,666 executives tracked by ExecPay. In other words, Schoenberg earned more than 40.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,742 out of 14,666 | 40th |
Division Manufacturing | 3,331 out of 5,772 | 42nd |
Major group Chemicals And Allied Products | 1,128 out of 2,075 | 46th |
Industry group Drugs | 897 out of 1,731 | 48th |
Industry Pharmaceutical Preparations | 704 out of 1,333 | 47th |
Source: SEC filing on April 26, 2019.
Schoenberg's colleagues
We found three more compensation records of executives who worked with Mark Schoenberg at UroGen Pharma Ltd. in 2017.